SIETES :: 92806 citas

Resultados de la búsqueda por ANTECEDENTES FAMILIARES REFINAR BÚSQUEDA

1.

Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy. A review. JAMA 2019;321:15 de enero. [Ref.ID 103008]

2.

Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010;340:1231. [Ref.ID 88637]

3.

Scott I. Improving the accuracy of predicting cardiovascular risk. BMJ 2010;340:1206-7. [Ref.ID 88633]

4.

Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009;339:144-7. [Ref.ID 86344]

5.

Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for predicting cardiovascular risk?. BMJ 2009;339:115-6. [Ref.ID 86339]

6.

Hippilsley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82. [Ref.ID 83403]

7.

Christiaens T. Cardiovascular risk tables. BMJ 2008;336:1445-6. [Ref.ID 83394]

8.

Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-31. [Ref.ID 82403]

9.

Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet 2008;371:878-9. [Ref.ID 82393]

10.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136-41. [Ref.ID 80710]

11.

Maestri E, Spettoli D, Basevi V, Borghi F, Sanguanini A, Magrini N. La contraccezione ormonale oggi. Informazioni sui Farmaci 2007;31:36-46. [Ref.ID 80536]

12.

Dove-Edwin I, Sasieni P, Adams J, Thomas HJW. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005;351:1047-9. [Ref.ID 75351]

13.

Kienle P. Patients at risk of familial colorectal cancer. BMJ 2005;351:1033-4. [Ref.ID 75343]

14.

Amorim MR, Castilla EE, Orioli I M. Is there a familial link between Down's syndrome and neural tube defects? Population and familial survey. BMJ 2004;328:84-7. [Ref.ID 68724]

15.

Grönberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64. [Ref.ID 65298]

16.

Qin P, Agerbo E, Mortensen PB. Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers. Lancet 2002;360:1126-30. [Ref.ID 63630]

17.

Bergfeldt K, Rydh B, Granath F, Grönberg H, Thalib L, Adami HO, Hall P. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 2002;360:891-4. [Ref.ID 63290]

18.

Murabito JM, Evans JC, Larson MG, Kreger BE, Splansky GL, Freund KM, Moskowitz MA, Wilson PWF. Family breast cancer history and mammography. Framingham Offspring Study. Am J Epidemiol 2001;154:916-23. [Ref.ID 59424]

19.

Cosmi B. Family history and risk of venous thromboembolism with oral contraception. Author's reply. BMJ 2001;323:752. [Ref.ID 58829]

20.

Vandenbroucke JP, van der Meer FJM, Helmerhorst FM, Rosendaal F R. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool. BMJ 2001;323:752. [Ref.ID 58828]